Publication:
Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study

Simple item page
dc.contributor.authorÖZGÜR, EMRAH GÖKAY
dc.contributor.authorsKAYA H., ÖKSÜZLER KIZILBAY G., ILGAZLI A. H., ÖZGÜR E. G.
dc.date.accessioned2023-12-18T07:45:38Z
dc.date.accessioned2026-01-11T06:03:30Z
dc.date.available2023-12-18T07:45:38Z
dc.date.issued2023-01-01
dc.identifier.citationKAYA H., ÖKSÜZLER KIZILBAY G., ILGAZLI A. H., ÖZGÜR E. G., "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study", EURASIAN JOURNAL OF PULMONOLOGY, 2023
dc.identifier.doi10.14744/ejp.2023.4009
dc.identifier.issn2148-5402
dc.identifier.urihttps://hdl.handle.net/11424/295711
dc.language.isoeng
dc.relation.ispartofEURASIAN JOURNAL OF PULMONOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleTocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study
dc.typearticle
dspace.entity.typePublication

Files

Collections

Araştırma Çıktıları